Precision Biosciences Inc (DTIL)

Dec 19, 2024

Precision gains CTA approval in Hong Kong for chronic hepatitis B therapy trial - Yahoo Finance

Dec 19, 2024

Dec 18, 2024

Precision BioSciences gets nod for HBV trial in Hong Kong - Investing.com

Dec 18, 2024

Dec 18, 2024

Precision BioSciences Receives Approval in Hong Kong to Expand PBGENE-HBV Phase 1 ELIMINATE-B Trial for the Treatment of Chronic Hepatitis B - Business Wire

Dec 18, 2024

Dec 12, 2024

Precision BioSciences stock hits 52-week low at $5.2 By Investing.com - Investing.com Nigeria

Dec 12, 2024

Dec 11, 2024

Precision BioSciences stock hits 52-week low at $5.2 - Investing.com India

Dec 11, 2024

Dec 08, 2024

(DTIL) Proactive Strategies - Stock Traders Daily

Dec 08, 2024

Dec 04, 2024

Precision BioSciences' SWOT analysis: gene editing firm's stock faces pivotal year - Investing.com UK

Dec 04, 2024

Dec 04, 2024

Precision BioSciences stock hits 52-week low at $6.4 By Investing.com - Investing.com South Africa

Dec 04, 2024

Dec 03, 2024

Precision BioSciences stock hits 52-week low at $6.4 - Investing.com

Dec 03, 2024

Dec 02, 2024

Precision BioSciences, Inc. (NASDAQ:DTIL) Short Interest Up 11.8% in November - MarketBeat

Dec 02, 2024

Nov 29, 2024

Gene Editing Market Forecast Report 2024, with Profiles of Merck, GenScript, Revvity, Lonza, Precision BioSciences, Cellectis, AMSBIO, Synthego, Takara Bio, Bio-Techne, Reprocell and More - Yahoo Finance

Nov 29, 2024

Nov 29, 2024

Precision BioSciences (NASDAQ:DTIL) Trading 3.6% HigherHere's What Happened - MarketBeat

Nov 29, 2024

Nov 28, 2024

Precision BioSciences (DTIL) Surges 6.1%: Is This an Indication of Further Gains? - MSN

Nov 28, 2024

Nov 22, 2024

Insider Buying: John Kelly Acquires Shares of Precision BioScien - GuruFocus.com

Nov 22, 2024

Nov 21, 2024

Precision BioSciences to Participate in Upcoming November Investor Conferences - BioSpace

Nov 21, 2024

Nov 21, 2024

Precision BioSciences to Present at Two Major Gene Editing Conferences in November | DTIL Stock News - StockTitan

Nov 21, 2024

Nov 17, 2024

Trading (DTIL) With Integrated Risk Controls - Stock Traders Daily

Nov 17, 2024

Nov 15, 2024

Gene Editing Tools Market Size, Growth Opportunities, - openPR

Nov 15, 2024

Nov 15, 2024

Precision BioSciences Highlights Preclinical Data and Outlines Design of First-in-Human Clinical Trial for PBGENE-HBV for Treatment of Chronic Hepatitis B - Business Wire

Nov 15, 2024

Nov 14, 2024

JANUS HENDERSON GROUP PLC's Strategic Acquisition in Precision B - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Precision BioSciences stock hits 52-week low at $7.94 By Investing.com - Investing.com Canada

Nov 14, 2024

Nov 14, 2024

Precision BioSciences stock hits 52-week low at $7.94 - Investing.com

Nov 14, 2024

Nov 14, 2024

Highbridge Capital Management's Strategic Acquisition of Precisi - GuruFocus.com

Nov 14, 2024

Nov 12, 2024

Avidity Biosciences Announces New Precision Cardiology Development Candidates to Treat Rare Genetic Cardiomyopathies and Provides First Look at Next-Generation Technology Innovations - PR Newswire

Nov 12, 2024

Nov 07, 2024

What is HC Wainwright's Forecast for DTIL FY2024 Earnings? - MarketBeat

Nov 07, 2024

Nov 06, 2024

Research Analysts Offer Predictions for DTIL FY2027 Earnings - MarketBeat

Nov 06, 2024

Nov 06, 2024

(DTIL) Technical Data - Stock Traders Daily

Nov 06, 2024

Nov 05, 2024

Precision Biosciences CEO Michael Amoroso sells shares worth $24,668 - Investing.com India

Nov 05, 2024

Nov 05, 2024

Precision Biosciences' general counsel sells $4,815 in stock - Investing.com

Nov 05, 2024

Nov 05, 2024

Precision Biosciences' general counsel sells $4,815 in stock By Investing.com - Investing.com UK

Nov 05, 2024

Nov 05, 2024

Precision BioSciences keeps $34 target, Market Perform rating By Investing.com - Investing.com Australia

Nov 05, 2024

Nov 04, 2024

Precision BioSciences: Q3 Earnings Snapshot - Darien Times

Nov 04, 2024

Nov 04, 2024

Precision BioSciences Reports Third Quarter 2024 Financial Results and Provides Business Update - BioSpace

Nov 04, 2024

Nov 04, 2024

Precision BioSciences keeps $34 target, Market Perform rating - Investing.com

Nov 04, 2024

Nov 04, 2024

Precision BioSciences (DTIL) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance

Nov 04, 2024

Oct 31, 2024

Avidity Biosciences to Host Investor and Analyst Event Focused on Precision Cardiology Candidates and First Look at Next-Generation Technology Innovations on November 12, 2024 - PR Newswire

Oct 31, 2024

Oct 31, 2024

Precision BioSciences Announces FDA Accepts IND for PBCAR19B, a Next-Generation, Stealth Cell, CD19 Allogeneic CAR T Candidate for Non-Hodgkin Lymphoma - Marketscreener.com

Oct 31, 2024

Oct 30, 2024

Precision BioSciences (DTIL) Set to Announce Earnings on Monday - MarketBeat

Oct 30, 2024

Oct 29, 2024

Precision BioSciences to Report Third Quarter Results on November 4, 2024 - BioSpace

Oct 29, 2024